Skip to main
RETA
RETA logo

Reata Pharmaceuticals (RETA)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Reata Pharmaceuticals (RETA) Stock

About Reata Pharmaceuticals (RETA)

Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff ...read more
Market cap$6.57B
Today's volume
Revenue (TTM)
Avg. daily volume908.34K
EBITDA (TTM)
Open
Price / earnings ratio-57.67x
Today's range
Debt / equity
52 week range$21.83 - $172.46
5 year debt / equity32.12x
Beta (LTM)0.58x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsDec 31, 2024
Dividend payable date

Reata Pharmaceuticals Stock Rating

What analysts recommend for RETA stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 21%
Buy 36%
Hold 43%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 18, 2025, the market cap for RETA stock is $6.57B

The current P/E ratio for RETA stock is -57.67

The 52-week high for RETA stock is $172.46. The current RETA stock price $undefined is 100.00% below its 52-week high

The 52-week low for RETA stock is $21.83. The current RETA stock price $undefined has increased 100.00% from its 52-week low

No, the RETA stock does not pay dividends to its shareholders

The target price for RETA stock is $144.57 based on the average of what a group of analyst think RETA stock could be worth at a future date. This is not a prediction by Public.com

How to buy RETA stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in RETA stock

    Navigate to the Explore page. Then, type RETA into the search bar. When you see RETA stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased RETA stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Reata Pharmaceuticals Stock Earnings

The value each RETA share was expected to gain vs. the value that each RETA share actually gained.

Reata Pharmaceuticals (RETA) reported Q2 2023 earnings per share (EPS) of -$1.58, beating estimates of -$2.09 by 24.40%. In the same quarter last year, Reata Pharmaceuticals's earnings per share (EPS) was -$1.36. Reata Pharmaceuticals is expected to release next earnings on 12/31/2024, with an earnings per share (EPS) estimate of $0.

Buy Reata Pharmaceuticals (RETA) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.